Description

Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier.com/locate/series/seda) continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction. The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.

Key Features

*Provides a critical yearly survey of new data and trends *Includes an essay that describes the modern approach to classifying adverse drug reactions *Special reviews in this Annual include, among other topics: Antipsychotic drugs and now-onset diabetes mellitus, Treating asthma during pregnancy, and MMR vaccine and autism

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, Clinical pharmacologists, and medical libraries

Table of Contents

Contributors

Special reviews

Cumulative index of special reviews, Annuals 14–27

Table of Essays, Annuals 1–27

How to use this book

Side Effects of Drugs Essay: Classifying adverse drug reactions in the 21st century

Central nervous system stimulants and drugs that suppress appetite

Antidepressant drugs

Lithium

Drugs of abuse

Hypnosedatives and anxiolytics

Antipsychotic drugs

Antiepileptic drugs

Opioid analgesics and narcotic antagonists

Antiinflammatory and antipyretic analgesics and drugs used in gout

General anesthetics and therapeutic gases

Local anesthetics

Neuromuscular blocking agents and skeletal muscle relaxants

Drugs that affect autonomic functions or the extrapyramidal system/

Dermatological drugs, topical agents, and cosmetics

Antihistamines (H1 receptor antagonists)

Drugs acting on the respiratory tract

Positive inotropic drugs and drugs used in dysrhythmias

Beta-adrenoceptor antagonists and antianginal drugs

Drugs acting on the cerebral and peripheral circulations

Antihypertensive drugs

Diuretics

Metals

Metal antagonists

Antiseptic drugs and disinfectants

Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines

Miscellaneous antibacterial drugs

Antifungal drugs

Antiprotozoal drugs

Antiviral drugs

Drugs used in tuberculosis and leprosy

Antihelminthic drugs

Vaccines

Blood, blood components, plasma, and plasma products

Formulations used in nutrition

Drugs affecting blood coagulation, fibrinolysis, and hemostasis

Gastrointestinal drugs

Drugs that act on the immune system: cytokines and monoclonal antibodies

Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs

Details

No. of pages:
694
Language:
English
Copyright:
© 2005
Published:
Imprint:
Elsevier Science
Print ISBN:
9780444515711
Electronic ISBN:
9780080459509

About the editor

Jeffrey K. Aronson

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.